INVENTRONICS LTD (IVX.CA) Stock Fundamental Analysis
TSX-V:IVX - TSX Venture Exchange - CA4612082095 - Common Stock - Currency: CAD
We assign a fundamental rating of 4 out of 10 to IVX. IVX was compared to 3 industry peers in the Building Products industry. IVX has an average financial health and profitability rating. IVX has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
IVX had negative earnings in the past year.
In the past year IVX had a positive cash flow from operations.
IVX had positive earnings in each of the past 5 years.
Each year in the past 5 years IVX had a positive operating cash flow.
1.2 Ratios
IVX has a worse Return On Assets (-0.45%) than 66.67% of its industry peers.
The Return On Equity of IVX (-1.08%) is worse than 66.67% of its industry peers.
The Return On Invested Capital of IVX (1.57%) is worse than 66.67% of its industry peers.
IVX had an Average Return On Invested Capital over the past 3 years of 25.37%. This is significantly above the industry average of 3.70%.
The last Return On Invested Capital (1.57%) for IVX is well below the 3 year average (25.37%), which needs to be investigated, but indicates that IVX had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.45% | ||
| ROE | -1.08% | ||
| ROIC | 1.57% |
ROA(3y)25.64%
ROA(5y)20.23%
ROE(3y)56.04%
ROE(5y)50.36%
ROIC(3y)25.37%
ROIC(5y)18.8%
1.3 Margins
IVX's Profit Margin has improved in the last couple of years.
IVX's Operating Margin of 1.92% is on the low side compared to the rest of the industry. IVX is outperformed by 66.67% of its industry peers.
In the last couple of years the Operating Margin of IVX has remained more or less at the same level.
The Gross Margin of IVX (12.24%) is worse than 66.67% of its industry peers.
In the last couple of years the Gross Margin of IVX has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.92% | ||
| PM (TTM) | N/A | ||
| GM | 12.24% |
OM growth 3Y-0.49%
OM growth 5Y-0.85%
PM growth 3Y-29.97%
PM growth 5Y64.42%
GM growth 3Y0.27%
GM growth 5Y1.81%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IVX is creating value.
The number of shares outstanding for IVX has been increased compared to 1 year ago.
The number of shares outstanding for IVX has been increased compared to 5 years ago.
Compared to 1 year ago, IVX has a worse debt to assets ratio.
2.2 Solvency
IVX has an Altman-Z score of 2.06. This is not the best score and indicates that IVX is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of IVX (2.06) is better than 66.67% of its industry peers.
IVX has a debt to FCF ratio of 6.43. This is a slightly negative value and a sign of low solvency as IVX would need 6.43 years to pay back of all of its debts.
With a Debt to FCF ratio value of 6.43, IVX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.92 indicates that IVX is somewhat dependend on debt financing.
IVX's Debt to Equity ratio of 0.92 is on the low side compared to the rest of the industry. IVX is outperformed by 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | 6.43 | ||
| Altman-Z | 2.06 |
ROIC/WACC0.18
WACC8.81%
2.3 Liquidity
IVX has a Current Ratio of 2.94. This indicates that IVX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of IVX (2.94) is better than 100.00% of its industry peers.
A Quick Ratio of 2.06 indicates that IVX has no problem at all paying its short term obligations.
IVX has a better Quick ratio (2.06) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.94 | ||
| Quick Ratio | 2.06 |
3. Growth
3.1 Past
IVX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -103.16%.
IVX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 83.94% yearly.
The Revenue for IVX has decreased by -44.86% in the past year. This is quite bad
Measured over the past years, IVX shows a quite strong growth in Revenue. The Revenue has been growing by 13.93% on average per year.
EPS 1Y (TTM)-103.16%
EPS 3Y-21.27%
EPS 5Y83.94%
EPS Q2Q%133.16%
Revenue 1Y (TTM)-44.86%
Revenue growth 3Y16.24%
Revenue growth 5Y13.93%
Sales Q2Q%9.64%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
IVX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IVX is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
100.00% of the companies in the same industry are more expensive than IVX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.81 | ||
| EV/EBITDA | 13.41 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
IVX has a Yearly Dividend Yield of 18.52%, which is a nice return.
In the last 3 months the price of IVX has falen by -22.86%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 18.52, IVX pays a better dividend. On top of this IVX pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, IVX pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 18.52% |
5.2 History
IVX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IVX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1803.7%
EPS Next 2YN/A
EPS Next 3YN/A
TSX-V:IVX (3/7/2025, 7:00:00 PM)
0.54
0 (0%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners8.93%
Ins Owner ChangeN/A
Market Cap2.63M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 18.52% |
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP-1803.7%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.44 | ||
| P/FCF | 6.81 | ||
| P/OCF | 5.03 | ||
| P/B | 1.05 | ||
| P/tB | 1.05 | ||
| EV/EBITDA | 13.41 |
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.08
FCFY14.68%
OCF(TTM)0.11
OCFY19.89%
SpS1.22
BVpS0.51
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.45% | ||
| ROE | -1.08% | ||
| ROCE | 2.26% | ||
| ROIC | 1.57% | ||
| ROICexc | 1.91% | ||
| ROICexgc | 1.91% | ||
| OM | 1.92% | ||
| PM (TTM) | N/A | ||
| GM | 12.24% | ||
| FCFM | 6.5% |
ROA(3y)25.64%
ROA(5y)20.23%
ROE(3y)56.04%
ROE(5y)50.36%
ROIC(3y)25.37%
ROIC(5y)18.8%
ROICexc(3y)27.58%
ROICexc(5y)20.23%
ROICexgc(3y)27.58%
ROICexgc(5y)20.23%
ROCE(3y)36.51%
ROCE(5y)27.06%
ROICexcg growth 3Y3.44%
ROICexcg growth 5Y2.41%
ROICexc growth 3Y3.44%
ROICexc growth 5Y2.41%
OM growth 3Y-0.49%
OM growth 5Y-0.85%
PM growth 3Y-29.97%
PM growth 5Y64.42%
GM growth 3Y0.27%
GM growth 5Y1.81%
F-Score3
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | 6.43 | ||
| Debt/EBITDA | 7.3 | ||
| Cap/Depr | 68.16% | ||
| Cap/Sales | 2.31% | ||
| Interest Coverage | 0.79 | ||
| Cash Conversion | 166.03% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.94 | ||
| Quick Ratio | 2.06 | ||
| Altman-Z | 2.06 |
F-Score3
WACC8.81%
ROIC/WACC0.18
Cap/Depr(3y)276.85%
Cap/Depr(5y)231.35%
Cap/Sales(3y)4.69%
Cap/Sales(5y)3.97%
Profit Quality(3y)110.21%
Profit Quality(5y)117.96%
High Growth Momentum
Growth
EPS 1Y (TTM)-103.16%
EPS 3Y-21.27%
EPS 5Y83.94%
EPS Q2Q%133.16%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.86%
Revenue growth 3Y16.24%
Revenue growth 5Y13.93%
Sales Q2Q%9.64%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-91.35%
EBIT growth 3Y15.67%
EBIT growth 5Y12.96%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-79.69%
FCF growth 3Y29.04%
FCF growth 5Y26.8%
OCF growth 1Y-75.45%
OCF growth 3Y40.67%
OCF growth 5Y46.91%